Farms.com Home   News

Acceligen successfully breeds gene-edited pigs with PRRS resistance

Acceligen, a leading innovator in sustainable agriculture, is proud to announce the breeding of gene-edited pigs with resistance to porcine reproductive and respiratory syndrome. This breakthrough represents a significant step forward in the pursuit for sustainable and ethical pork production.

PRRS is the most devastating disease to the swine industry in the United States, affecting not only the productivity of pigs, but also their health and wellness.  This regularly occurring and complex disease has been documented to cause an estimated $500 million USD of losses to the pork producers, thus affecting the food security of countless people around the world.

Click here to see more...

Trending Video

How Novonesis is Reshaping Swine Nutrition with Enzymes, Probiotics & Biological Solutions

Video: How Novonesis is Reshaping Swine Nutrition with Enzymes, Probiotics & Biological Solutions


The merger of Novozymes and Chr. Hansen created Novonesis, a global biosolutions leader combining more than a century of expertise in enzymes, probiotics and microbial science. In this exclusive interview, Keith Kinsley discusses how bringing these two industry innovators together is creating new opportunities for pork producers across North America and around the world.

Keith explains how Novonesis is leveraging the strengths of both legacy companies to deliver a more integrated approach to swine nutrition, gut health and feed efficiency. From sow productivity and piglet development to grow-finish performance, Novonesis offers science-backed biological solutions designed to help producers maximize feed utilization, support microbiome robustness and improve overall herd performance.